Interim Report Q2, 2023: Calliditas Therapeutics ...Middle East

Filing for full approval of TARPEYO STOCKHOLM, Aug. 17, 2023 /PRNewswire/ -- FINANCIAL SUMMARY FOR THE GROUP Key Figures April 1 - June 30, 2023 Net sales amounted to SEK 269.4 million, of which TARPEYO® net sales amounted to SEK 259.2 million, for the three months ended June 30, 2023....

Hence then, the article about interim report q2 2023 calliditas therapeutics was published today ( Thursday 17/08/2023 - 08:37 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Interim Report Q2, 2023: Calliditas Therapeutics )

Also on site :

• ‘The Young and the Restless’ Legend Eileen Davidson Reveals How One ‘Topical’ Storyline Literally Saved Fans’ Lives (Exclusive)
• Think 2026: IBM Makes Digital Sovereignty Operational with General Availability of IBM Sovereign Core
• DC vs CSK Dream11 Prediction Today Match, Dream11 Team Today, Fantasy Cricket Tips, Playing XI, Pitch Report, Injury Update- IPL 2026, Match 48